Recente Updates
- Latest news on Cell and gene therapy CRO market Research Report by 2035
Characterized by high prevalence rate of rare and genetic disorders, and rise in demand for effective novel ATMPs, the cell and gene therapy contract research industry is likely to witness evolutionary advancements, in the coming years
Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell and Gene Therapy CROs Market, 2022-2035”.
The report features an extensive study of the current market landscape, offering an informed opinion on the likely adoption of these therapies over the next decade. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the study includes:
A detailed overview of the overall market landscape of the cell and gene therapy CROs, based on several relevant parameters, such as year of establishment, company size, location of headquarters, area of expertise, scale of operation and types of services offered.
A detailed analysis on the business models that are commonly adopted by the biopharmaceutical industry for outsourcing cell and gene therapies.
Elaborate profiles of key industry players based in North America, Europe and Asia-Pacific that offer contract research services.
A benchmark analysis of the various players engaged in this domain. It highlights the capabilities of the companies.
An analysis of the recent collaborations within the cell and gene therapy contract research industry, during the period 2015-2022.
A detailed analysis of the various mergers and acquisitions that have taken place in this domain, during the period 2015-2022.
A detailed acquisition target analysis, taking into consideration historical trend of the activity of players that have acquired other firms since 2015.
A detailed discussion on affiliated trends, key drivers and challenges, under a SWOT framework, which are likely to impact the industry’s evolution highlighting the relative effect of each SWOT parameter on the overall cell and gene therapies research services industry.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Area of Expertise
Cell Therapy
Gene Therapy
Scale of Operation
Preclinical
Clinical
Drug Discovery
Therapeutic Area
Oncological Disorders
Neurological Disorders
Cardiovascular Disorders
Infectious Diseases
Metabolic Disorders
Autoimmune Disorders
Blood Disorders
Rare / Genetic Disorders
Ophthalmic Disorders
Other disorders
Analysis by Geographical Regions
North America
Europe
Asia Pacific
Latin America
Middle East and North Africa
Key companies covered in the report
Altasciences
Charles River Laboratories
Creative Biolabs
IQVIA
Medpace
PPD
Precision for Medicine
Accelera
Evotec
ICON
Syneos Health
CMIC Group
Labcorp
To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/view_document/cell-and-gene-therapy-cros-market/230.html
News article
AI-based digital pathology market
Learn from experts: do you know about these emerging industry trends?
TCR Therapies: An Emerging Therapeutic Modality
Cell Therapy – The Revolutionary Therapeutic Modality: All Set To Obliterate Oncological Disorders
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#atmps #genetherapycro #cellandgenetherapycompanies #MarketResearch #MarketInsights
0 0 Reacties 0 Aandelen - Lab Automation market Share, Growth Analysis by 2035
The diverse applications of lab automation systems, including advanced data management, high reproducibility and increased productivity in the biotechnology and pharmaceutical industries, have allowed the researchers to focus on more complex tasks.
As a result, several stakeholders have been engaged in the manufacturing of user-friendly, controlled and automated instruments that can be customized as per the needs of the laboratory.
The USD 7.5 billion (by 2035) financial opportunity within the lab automation market has been analyzed across the following segments:
Stage of Automation
Pre-Analytical
Analytical
Post-Analytical
Total Lab Automation
Type of Instrument
Automated Liquid Handling Systems
Automated Microplate Readers
Automated Sampling Systems
Analyzers
Automated Storage and Retrieval Systems (ASRS)
Other Instruments
End-User
Pharmaceutical and Biotechnology Companies
Research and Diagnostic Laboratories
Other End-Users
Key Geographical Regions
North America
Europe
Asia-Pacific
Middle East and North Africa
Latin America
The Lab Automation Market, 2023-2035 report features the following companies, which we identified to be key players in this domain:
Abbott
Anton Paar
BD
Beckman Coulter
ERWEKA
Leuze
Ortho Clinical Diagnostics
Pall Corporation
PerkinElmer
Roche Diagnostics
Siemens Healthineers
SYSTAG
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape
5. Company Competitiveness Analysis
6. Company Profiles
7. Partnerships and Collaborations
8. Patent Analysis
9. Market Forecast and Opportunity Analysis
10. Case Study: Lab Automation Software
11. Executive Insights
12. Appendix 1: Tabulated Data
13. Appendix 2: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/lab-automation-market.html
News article
Biopharmaceutical Filtration Market
Learn from experts: do you know about these emerging industry trends?
CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications
T-cell Immunotherapies: The Future of Modern Cancer Treatments
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#labautomation #laboratoryautomation #laboratoryautomationmarket #MarketResearch #MarketInsights
0 0 Reacties 0 Aandelen - Cell Free Expression market Analysis and Trends by 2023-2035
The growing pipeline of biologics and challenges associated with their manufacturing have prompted stakeholders in the biopharmaceutical industry to adopt cell free expression systems for effective synthesis of biotherapeutics
Roots Analysis is pleased to announce the publication of its recent study, titled, “Cell Free System: Cell Free Expression Kits and Service Providers, 2023-2035.”
The market report presents an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this industry, across different regions. Amongst other elements, the research report includes:
An executive summary of insights captured during our research.
A general overview of cell free systems, the different types of such systems and their composition. It provides a brief outline of the cell free expression process, highlighting several challenges and advantages associated with this technique
A detailed assessment of the current market landscape of cell free expression service providers.
A detailed assessment of the current market landscape of cell free expression kits, based on several relevant parameters.
A comprehensive company competitiveness analysis of cell free expression service providers.
A product competitiveness analysis of cell free expression kits based on various relevant parameters.
Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) offering cell free expression services.
Elaborate profiles of prominent players engaged in development of cell free expression kits (shortlisted based on a proprietary criterion).
A detailed analysis of recent partnerships inked between stakeholders engaged in this industry, from 2018.
An analysis of the funding and investments made in the cell free expression market, since 2018.
An in-depth analysis of various patents that have been filed / granted related to cell free system since 2015.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Type of Cell Free System
• Crude Cell Lysate-based Systems
• Reconstituted Systems
Type of Host Organism
• Microbial Cell Free Expression Systems
• Mammalian Cell Free Expression Systems
• Plant-based Cell Free Expression Systems
• Other Cell Free Expression Systems
Type of Expression Method
• Coupled Transcription and Translation Method
• Translation Method
End-User
• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Other End-Users
Key Geographical Regions
• North America
• Europe
• Asia Pacific
• Rest of the World
Key companies covered in the report
BioLinker
biotechrabbit
CellFree Sciences
Creative Biolabs
CUSABIO
Daicel Arbor Biosciences
LenioBio
Promega
Thermo Fisher Scientific
Touchlight
For additional details, please visit https://www.rootsanalysis.com/reports/cell-free-expression-market.html
News article
Biopharmaceutical Filtration Market
Learn from experts: do you know about these emerging industry trends?
CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications
Antiviral Drugs: The Unmet Requirement in the Pharmaceutical Space
Learn from our recently published whitepaper: -
Next Generation Biomanufacturing – The Upcoming Era of Digital Transformation
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#Cellfreeproteinsynthesis #cellfreeproteinsynthesis #cellfreesystem #MarketResearch #MarketInsights
0 0 Reacties 0 Aandelen - Latest news on mRNA therapeutics and Vaccines market Research Report by 2035
The “mRNA Therapeutics and Vaccines Market: Industry Trends and Global Forecasts, 2022 – 2035” report features an extensive study of the current market landscape and the likely future potential associated with the biopharmaceutical contract manufacturing market, over the next decade.
The study also includes an elaborate discussion on the future potential of this evolving market. Amongst other elements, the report features:
Key Inclusions
A detailed overview of the overall market landscape of mRNA therapeutics and vaccines, based on several relevant parameters, such as phase of development (marketed, phase III, phase II, phase I / II, phase I, preclinical and discovery), type of drug candidate (mRNA therapeutic and mRNA vaccine), therapeutic area (infectious diseases, oncological disorders, genetic disorders, pulmonary disorders, autoimmune disorders and other disorders), type of delivery system used (lipid nanoparticles, lipopolyplex, liposomes, direct transfer, self-amplifying RNA platform and others), type of molecule encoded (spike protein, glycoprotein, antigen, cytokine, protein coding gene, tumor neoantigen, enzyme, tumor antigen and others) and route of administration (intramuscular, intravenous, intranasal and others).
A detailed overview of the current mRNA therapeutics and mRNA vaccine market of players engaged in the development of mRNA therapeutics and vaccines, along with information on their year of establishment, company size (in terms of number of employees), location of headquarters, regional landscape and key players engaged in this domain.
An in-depth company competitiveness analysis of mRNA therapeutics and vaccines developers based on their portfolio strength (in terms of year of establishment and company size), pipeline strength (in terms of its pipeline maturity and drug administration route) and number of therapeutic areas targeted.
Detailed profiles of marketed and late stage (phase III) mRNA therapeutics and vaccines, along with information on the development timeline of the therapy, current development status, primary target indication, therapeutic area, type of molecule encoded, type of delivery system used, affiliated technology, recent partnerships associated with the drug, clinical trial results related to the drug and other recent developmental.
A review of the various mRNA-focused initiatives undertaken by big pharma players (shortlisted on the basis of the revenues generated in 2021), featuring a [A] heat map representation that highlights mRNA therapeutics and vaccines under development (in partnership with core mRNA-focused entities), along with information on funding amount raised, partnership activity, and diversity of product portfolio (in terms of disease indication(s) being treated and focus therapeutic area(s)), as well as [B] a spider web representation, comparing the initiatives of big pharmaceutical players on the basis of multiple relevant parameters.
An analysis of start-ups (established between 2016-2022) engaged in this domain, based on several relevant parameters, such as number of candidates in discovery, preclinical and clinical phases of development, amount raised, number of investors and number of deals inked.
An analysis of completed, ongoing and planned clinical studies of mRNA therapeutics and vaccines, based on several relevant parameters, such as trial registration year, trial status, trial phase, target therapeutic area, study design, type of sponsor / collaborator, leading industry players (in terms of number of trials conducted), enrolled patient population and key geographical regions.
An analysis of recent collaborations and partnerships within the mRNA therapeutics and vaccines industry, based on several relevant parameters, such as year of partnership, type of partnership, targeted therapeutic area, most active players (in terms of number of deals inked) and regional distribution of partnership activity that have been undertaken in this domain, during the period 2013-2022.
A detailed analysis of various investments made by players engaged in this domain, during the period 2013-2022, based on several relevant parameters, such as year of funding, type of funding (seed financing, venture capital, IPOs, secondary offerings, debt, grants and other offerings), amount invested, therapeutic area, most active players (in terms of number of funding instances and amount invested) and key investors (in terms of number of funding instances).
An in-depth analysis of the various patents that have been filed / granted related to mRNA therapeutics and vaccines domain, since 2016, based on several relevant parameters, such as type of patent (granted patents, patent applications and others), publication year, geographical region, CPC symbols, leading industry players (in terms of the number of patents filed / granted) and patent valuation.
The report also features the likely distribution of the current and forecasted opportunity across important market segments, mentioned below:
Routes of Administration
Intradermal
Intravenous
Intranasal
Others
Therapeutic Area
Infectious Diseases
Oncological Disorders
Other Disorders
Key Geographical Regions
North America
Europe
Asia-Pacific
Latin America
Middle East and North Africa
Key Questions Answered
Which are the key players engaged in the development of mRNA therapeutics and vaccines?
Which mRNA drug candidates are being evaluated across early and late stages of clinical development?
Which are the key therapeutic areas targeted by mRNA therapeutics and vaccines?
Which type of delivery systems are primarily being used for the delivery of mRNA therapeutics and vaccines?
Which are the most active trial sites (in terms of number of clinical studies being conducted) related to mRNA therapeutics and vaccines?
Which companies are actively filing patents in order to drive innovation in the field of mRNA therapeutics and vaccines?
What type of partnership models are commonly adopted by stakeholders in the mRNA therapeutics and vaccine domain?
Which are the companies that are investing heavily in this domain?
How is the current and future market opportunity likely to be distributed across the various key market segments?
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/mrna-therapeutics-and-vaccines-market.html
News article
Modular Facility Manufacturers Market
Learn from experts: do you know about these emerging industry trends?
Novel Cell Cytometers: Need of the Hour
Antiviral Drugs: The Unmet Requirement in the Pharmaceutical Space
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Learn more about Roots Analysis consulting services:
Roots Analysis Consulting - the preferred research partner for global firms
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#mrnatherapeuticscompanies #mrnavaccinecompanies #mrnatechnology #MarketResearch #MarketInsights
0 0 Reacties 0 Aandelen - Digital twin market Share, Growth Analysis by 2035
Given the potential of digital twins to replicate the physical world in a digital layout, as well as their ability to provide real-time outputs, while gathering constant inputs from the real-world, such products have generated significant interest within the healthcare domain
The USD 29.8 billion (by 2035) financial opportunity within digital twin market has been analyzed across the following segments:
Therapeutic Area
Cardiovascular Disorders
Metabolic Disorders
Orthopedic Disorders
Other Disorders
Type of Digital Twin
Process Twins
System Twins
Whole Body Twins
Body Part Twins
Area of Application
Asset / Process Management
Personalized Treatment
Surgical Planning
Diagnosis
Other Applications
End Users
Pharmaceutical Companies
Medical Device Manufacturers
Healthcare Providers
Patients
Other End Users
Key Geographical Regions
North America
Europe
Asia
Latin America
Middle East and North Africa
Rest of the World
The Digital Twins Market, 2022-2035, report features the following companies, which we identified to be key players in this domain:
Babylon
ExactCure
ImmersiveTouch
Navv Systems
ThoughtWire
Unlearn.AI
The latest report also provides key insights for Digital Twin Technology and Digital Twins Providers
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Market Landscape
5. Key Insights
6. Company Competitiveness Analysis
7. Company Profiles
8. Partnerships and Collaborations
9. Funding and Investments Analysis
10. Berkus Start-up Valuation Analysis
11. Market Forecast
12. Conclusion
13. Executive insights
14. Appendix I: Tabulated data
15. Appendix II: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/digital-twins-market.html
You may also be interested in the following titles:
Buffer Preparation Market
mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends
Quantum Computing in Drug Discovery Services Market
Roots Analysis Consulting - the preferred research partner for global firms
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#DigitalTwins #DigitalTwin #DigitalTwinTechnology #MarketResearch #MarketInsights
0 0 Reacties 0 Aandelen - Bacteriophage therapy market Professional Survey Report by 2035
With the ever-increasing burden of antimicrobial resistance, the focus of the research community has shifted towards the development of alternatives for the treatment of infectious diseases.
One of such alternatives is bacteriophage therapeutics. The innovators suggests that the success of these therapies lies in the effectiveness of phages to target the desired bacterial strains.
The financial opportunity within the bacteriophage therapeutics market has been analyzed across the following segments:
Type of Therapeutic Area
Infectious Diseases
Oncological Disorders
Other Disorders
Distribution by Route of Administration
Oral Route
Rectal Route
Intravesical Route
Topical Route
Key Geographical Regions
North America
Europe
Asia-Pacific
Latin America
Middle East and North Africa
The “Bacteriophage Therapy Market, 2022-2035” report features the following companies, which we identified to be key players in this domain:
Adaptive Phage Therapeutics
ContaFect
Eliava BioPreparations
Micreos
NPO Microgen
Phagelux
Pherecydes Pharma
Table of Content
1. PREFACE
2. EXECUTIVE SUMMARY
3. INTRODUCTION
4. BACTERIO-PHAGE THERAPY: MARKET LANDSCAPE
5. BACTERIOPHAGE THERAPEUTICS: DEVELOPER LANDSCAPE
6. COMPANY AND DRUG PROFILES
7. CLINICAL TRIAL ANALYSIS
8. PATENT ANALYSIS
9. PUBLICATION BENCHMARKING ANALYSIS
10. ACADEMIC GRANTS ANALYSIS
11. FUNDING AND INVESTMENT ANALYSIS
12. PARTNERSHIPS AND COLLABORATIONS
13. START-UP HEALTH INDEXING
14. MARKET FORECAST AND OPPORTUNITY ANALYSIS
15. CONCLUSION
16. EXECUTIVE INSIGHTS
17. APPENDIX I: TABULATED DATA
18. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS
For additional details, please visit https://www.rootsanalysis.com/reports/bacteriophage-therapy-market.html
You may also be interested in the following titles:
Cannabis Testing Market
Key Trends in Non-Viral Transfection Market
CAR-T Cell Therapy Market
Roots Analysis Consulting - the preferred research partner for global firms
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#bacteriophagetherapy #bacteriophagetherapeutics #phagetherapy #MarketResearch #MarketInsights
0 0 Reacties 0 Aandelen - Medical Device coating market Growth Analysis by 2035
The growing demand for complex medical devices has prompted developers to innovate and introduce biocompatible, high-performance medical device coatings that can meet the operational, clinical, and engineering requirements for these devices.
Presently, multiple types of medical device coating are available in the market to accommodate the multifunctionality of novel medical devices. A detailed medical device coating market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):
Type of Devices Coated
Class I Medical Devices
Class II Medical Devices
Class III Medical Devices
Type of Coating Material
Polymer Coatings
Metal Coatings
Other Coatings
Company Size
Very Small
Small
Mid-sized
Large
Very Large
Key Geographical Region
North America
Europe
Asia
Rest of the World
Key companies covered in the report
Advanced Coating
Biocoat
Evonik
Formacoat
Harland Medical Systems
Para-Coat Technologies
Specialty Coating Systems
SurModics
TUA Systems
Table of Contents
1. Preface
2. Executive Summary
3. Introduction
4. Medical Device Coating Providers: Market Landscape
5. Company Competitiveness Analysis
6. Surface Modification Technologies and Coating Solutions: Market Landscape
7. Product Competitiveness Analysis
8. Medical Device Coating Providers: Company Profiles
9. Partnerships and Collaborations
10. Medical Device Coating Providers: Pestle Analysis
11. Market Forecast
12. Concluding Remarks
13. Executive Insights
14. Appendix 1: Tabulated Data
15. Appendix 2: List of Companies and Organizations
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/medical-device-coatings-market.html
You may also be interested in the following titles:
Nanoparticle Formulation Market
4D Bioprinting Market: Key Trends
Global Digital Therapeutics Market
Roots Analysis Consulting - the preferred research partner for global firms
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#medicaldevicecoatingindustry #biocompatiblecoating #antimicrobialcoating #MarketResearch #MarketInsights
0 0 Reacties 0 Aandelen - Medical Device Coatings market 2022 – Industry Growth by 2035
Roots Analysis has done a detailed study on “Medical Device Coatings and Surface Modification Technologies Market, 2023-2035”, covering key aspects of the industry’s evolution and identifying potential future growth opportunities
Key Market Insights
Currently, more than 85 companies provide coatings that serve a wide array of functions and are compatible with a diverse array of substrate materials; majority of such players have entered this domain post 2,000
Companies engaged in this industry provide a wide range of coating materials for different types of medical devices; of these, close to 70% of the coatings are being offered for medical implants
In order to gain an edge in this competitive industry, coating providers are continuously undertaking initiatives to upgrade their existing material offerings and coating solutions for medical devices
Presently, more than 115 surface modification technologies and coating solutions are being offered by players to enhance the surface functions and resistance of medical devices
The current market landscape is highly fragmented, featuring the presence of both new entrants and established players across key geographical regions; majority of the players are based in the US
In pursuit of gaining a competitive edge, developers are making an active effort to incorporate advanced technologies into their respective portfolios of coatings / technologies and comply with evolving industry needs
The rising interest of stakeholders in surface modification of medical devices and coating solutions is reflected by the increasing number of partnerships established between various industry and non-industry players
Built on our intellectual capital, we have proposed a proprietary framework that can be applied to strengthen the strategic planning processes and risk management within the industry
With the rising demand for medical device coating solutions and services, the affiliated market for service providers is expected to grow at a steady annualized rate of 7.7% over the coming decade
The opportunity associated with the medical device coatings market is expected to be well distributed among players of different company sizes, with majority of the revenue being coming in from developed regions.
Table of Contents
1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Chapter Overview
3.2. Medical Device Coatings
3.2.1. Types of Medical Device Coatings
3.2.2. Lubricious Coatings
3.2.3. Antimicrobial Coatings
3.2.4. Hydrophilic Coatings
3.2.5. Advantages and Disadvantages of Medical Device Coatings
3.3. Surface Modification Technologies
3.3.1. Types of Surface Modification Technologies
3.3.2. Advantages and Disadvantages of Surface Modification Technologies
3.4. Future Perspectives
4. MEDICAL DEVICE COATING PROVIDERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. Medical Device Coatings Providers: Overall Market Landscape
4.2.1. Analysis by Year of Establishment
4.2.2. Analysis by Company Size
4.2.3. Analysis by Location of Headquarters
4.2.4. Analysis by Type of Company
4.2.5. Analysis by Type of Medical Device(s) Coated
4.2.6. Analysis by Nature of Coating Material(s)
4.2.7. Analysis by Type of Coating Material(s)
4.2.8. Analysis by Type of Coating(s)
4.2.9. Analysis by Type of Coating Function(s)
4.2.10. Analysis by Type of Compatible Substrate(s)
4.2.11. Analysis by Service(s) Offered
4.2.12. Analysis by Additional Feature(s) Offered
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Chapter Overview
5.2. Assumptions and Key Parameters
5.3. Methodology
5.4. Medical Device Coatings Providers: Company Competitiveness Analysis
5.4.1. Competitiveness Analysis: Very Small Companies
5.4.2. Competitiveness Analysis: Small Companies
5.4.3. Competitiveness Analysis: Mid-sized Companies
5.4.4. Competitiveness Analysis: Large Companies
5.4.5. Competitiveness Analysis: Very Large Companies
6. SURFACE MODIFICATION TECHNOLOGIES AND COATING SOLUTIONS: MARKET LANDSCAPE
6.1. Chapter Overview
6.2. Surface Modification Technologies and Coating Solutions: Overall Market Landscape
6.2.1. Analysis by Type of Medium(s) for Modification
6.2.2. Analysis by Type of Trademark Right
6.2.3. Analysis by Type of Surface Modification Process(s) Employed
6.2.4. Analysis by Type of Device(s) Coated
6.2.5. Analysis by Type of Medical Device(s) Coated
6.2.6. Analysis by Nature of Coating Material(s)
6.2.7. Analysis by Type of Coating(s) Applied
6.2.8. Analysis by Type of Resistance(s) Offered
6.2.9. Analysis by Type of Compatible Substrate(s)
6.2.10. Analysis by Additional Feature(s) Offered
6.3. Medical Device Surface Modification Technologies and Coating Solutions: Developer Landscape
6.3.1. Analysis by Year of Establishment
6.3.2. Analysis by Company Size
6.3.3. Analysis by Location of Headquarters
6.3.4. Most Active Players: Analysis by Number of Products Offered
7. PRODUCT COMPETITIVENESS ANALYSIS
7.1. Chapter Overview
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Product Competitiveness Analysis
7.4.1. Product Competitiveness Analysis: Technologies
7.4.1.1. Technologies Developed by Very Small and Small Companies
7.4.1.2. Technologies Developed by Mid-sized Companies
7.4.1.3. Technologies Developed by Large and Very Large Companies
7.4.2. Product Competitiveness Analysis: Coating Solutions
7.4.2.1. Coating Solutions Developed by Very Small and Small Companies
7.4.2.2. Coating Solutions Developed by Mid-sized Companies
7.4.2.3. Coating Solutions Developed by Large and Very Large Companies
8. MEDICAL DEVICE COATING PROVIDERS: COMPANY PROFILES
8.1. Chapter Overview
8.2. Advanced Coating
8.2.1. Company Overview
8.2.2. Recent Developments and Future Outlook
8.3. Biocoat
8.3.1. Company Overview
8.3.2. Recent Developments and Future Outlook
8.4. Evonik Health Care
8.4.1. Company Overview
8.4.2. Recent Developments and Future Outlook
8.5. Formacoat
8.5.1. Company Overview
8.5.2. Recent Developments and Future Outlook
8.6. Harland Medical Systems
8.6.1. Company Overview
8.6.2. Recent Developments and Future Outlook
8.7. Para-Coat Technologies
8.7.1. Company Overview
8.7.2. Recent Developments and Future Outlook
8.8. Specialty Coating Systems
8.8.1. Company Overview
8.8.2. Recent Developments and Future Outlook
8.9. SurModics
8.9.1. Company Overview
8.9.2. Recent Developments and Future Outlook
8.10. TUA Systems
8.10.1. Company Overview
8.10.2. Recent Developments and Future Outlook
9. PARTNERSHIPS AND COLLABORATIONS
9.1. Chapter Overview
9.2. Partnership Models
9.3. List of Partnerships and Collaborations
9.3.1. Analysis by Year of Partnership
9.3.2. Analysis by Type of Partnership
9.3.3. Analysis by Type of Partner
9.3.4. Analysis by Geography
9.3.5. Most Active Players: Analysis by Number of Partnerships
10. MEDICAL DEVICE COATING PROVIDERS: PESTLE ANALYSIS
10.1. Chapter Overview
10.2. Methodology
10.3. Key Factors
10.3.1. Political Factors
10.3.2. Economical Factors
10.3.3. Sociological Factors
10.3.4. Technological Factors
10.3.5. Legal Factors
10.3.6. Environmental Factors
10.4. PESTLE Analysis: Medical Device Coating Providers
10.4.1. Biocoat
10.4.2. Biomerics
10.4.3. Diamond-MT
10.4.4. Evonik Health Care
10.4.5. Fisher Barton
10.4.6. Formacoat
10.4.7. Freudenberg
10.4.8. Harland Medical Systems
10.4.9. Master Bond
10.4.10. Materion
10.4.11. N8 Medical
10.4.12. Para-Coat Technologies
10.4.13. Specialty Coating Systems
10.4.14. SurModics
10.4.15. Tractivus
10.5. Concluding Remarks
11. MARKET FORECAST
11.1. Chapter Overview
11.2. Key Assumptions and Forecast Methodology
11.3. Global Medical Device Coatings Market, 2023-2035
11.3.1. Global Medical Device Coatings Market: Distribution by Type of Medical Devices Coated, 2023 and 2035
11.3.1.1. Medical Device Coatings Market for Class I Devices, 2023-2035
11.3.1.2. Medical Device Coatings Market for Class II Devices, 2023-2035
11.3.1.3. Medical Device Coatings Market for Class III Devices, 2023-2035
11.3.2. Global Medical Device Coatings Market: Distribution by Type of Coating Material, 2023 and 2035
11.3.2.1. Medical Device Coatings Market for Polymer Coatings, 2023-2035
11.3.2.2. Medical Device Coatings Market for Metal Coatings, 2023-2035
11.3.2.3. Medical Device Coatings Market for Other Coatings, 2023-2035
11.3.3. Global Medical Device Coatings Market: Distribution by Company Size, 2023 and 2035
11.3.3.1. Medical Device Coatings Market for Very Small Companies, 2023-2035
11.3.3.2. Medical Device Coatings Market for Small Companies, 2023-2035
11.3.3.3. Medical Device Coatings Market for Mid-sized Companies, 2023-2035
11.3.3.4. Medical Device Coatings Market for Large Companies, 2023-2035
11.3.3.5. Medical Device Coatings Market for Very Large Companies, 2023-2035
11.3.4. Global Medical Device Coatings Market: Distribution by Key Geographical Regions, 2023 and 2035
11.3.4.1. Medical Device Coatings Market in North America, 2023-2035
11.3.4.2. Medical Device Coatings Market in Europe, 2023-2035
11.3.4.3. Medical Device Coatings Market in Asia, 2023-2035
11.3.4.4. Medical Device Coatings Market in the Rest of the World, 2023-2035
12. CONCLUDING REMARKS
13. EXECUTIVE INSIGHTS
13.1. Chapter Overview
13.2. Biocoat
13.2.1. Company Snapshot
13.2.2. Interview Transcript: Mark Eberhardt, Senior Director of Marketing
13.3. N8 Medical
13.3.1. Company Snapshot
13.3.2. Interview Transcript: Carl Genberg, Chief Scientific Officer
13.4. VaporTech
13.4.1. Company Snapshot
13.4.2. Interview Transcript: David Wayne, Director of Sales and Marketing
14. APPENDIX 1: TABULATED DATA
15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/medical-device-coatings-market.html
You may also be interested in the following titles:
Cell Therapy Manufacturing Market
Global TCR Therapy Market
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#MedicalDeviceCoatingsmarket #MedicalDeviceCoatingsmarketGrowth #MedicalDeviceCoatings #antimicrobialcoatingsformedicaldevices #surfacetreatmenttechnologies
0 0 Reacties 0 Aandelen - Quantum Computing market 2022 – Industry Growth by 2035
Roots Analysis has announced the addition of “Quantum Computing in Drug Discovery Services Market, 2023-2035” report to its list of offerings.
Key Market Insights
Presently, over 45 players around the globe claim to offer quantum computing services across different steps of drug discovery
Leveraging their expertise, 86% stakeholders offer such services across target discovery / identification, primarily focusing on oncological disorders
In pursuit of gaining a competitive edge, manufacturers claim to be steadily expanding their existing capabilities in order to enhance their service portfolio related to quantum computing
Grants worth over USD 70 million have been awarded to various organizations that have actively undertaken R&D efforts to evaluate the potential of quantum computing in drug discovery
A considerable increase in the partnership activity has been witnessed in the past few years; close to 50% of the collaborations were inked by firms based in the same region
More than 30 players, worldwide, claim to offer hardware-as-a-service for quantum computing in drug discovery, and have developed the required expertise in different types of computational approaches
Majority of the quantum computing hardware providers, headquartered in North America, were established before the year 2000; in fact, ~50% of the overall market landscape is catered to by large companies.
The rise in the adoption of quantum computing in the biopharmaceutical industry is anticipated to create profitable business opportunities for both software and hardware providers
Based on the pioneer-migrator-settler map, we have classified the software providers into different categories; a selection of pioneers is expected to provide valuable offerings to lead the market in the longer term
We expect the market to grow at an annualized rate of 14% in the coming decade; the opportunity is likely to be well distributed across types of drug discovery services, therapeutic areas and key geographical regions
Table of Contents
1. PREFACE
1.1. Introduction
1.2. Key Market Insights
1.3. Scope of the Report
1.4. Research Methodology
1.5. Frequently Asked Questions
1.6. Chapter Outlines
2. EXECUTIVE SUMMARY
3. INTRODUCTION
3.1. Overview of Quantum Computing in Drug Discovery
3.2. Drug Discovery and Development Timeline
3.3. Historical Evolution of Computational Drug Discovery Approaches
3.4. Classification of Quantum Computing Approaches
3.5. Applications of Quantum Computing in Drug Discovery Process
3.6. Advantages of Quantum Computing in Drug Discovery
3.7. Challenges Associated with Quantum Computing in Drug Discovery
3.8. Future Perspectives
4. MARKET LANDSCAPE: SOFTWARE PROVIDERS
4.1. Quantum Computing Software Providers: Overall Market Landscape
4.1.1. Analysis by Year of Establishment
4.1.2. Analysis by Company Size
4.1.3. Analysis by Location of Headquarters
4.1.4. Analysis by Business Capabilities
4.1.5. Analysis by Platform Capabilities
4.1.6. Analysis by Type of Drug Discovery Service(s) Offered
4.1.7. Analysis by Type of Molecule(s) Supported
4.1.8. Analysis by Compatible Computational Approaches
4.1.9. Analysis by End User(s)
4.1.10. Analysis by Therapeutic Area(s)
5. COMPANY COMPETITIVENESS ANALYSIS
5.1. Methodology and Key Parameters
5.2 Scoring Criteria
5.3. Company Competitiveness Analysis: Players based in North America (Peer Group I)
5.4. Company Competitiveness Analysis: Players based in Europe (Peer Group II)
5.5. Company Competitiveness Analysis: Players based in Asia-Pacific and Rest of the World (Peer Group III)
6. COMPANY PROFILES: SOFTWARE PROVIDERS
6.1. Accenture
6.1.1. Company Overview
6.1.2. Financial Information
6.1.3. Service Portfolio
6.1.4. Recent Developments and Future Outlook
6.2. Atos
6.3. Fujitsu
6.4. Huawei
6.5. Microsoft
6.6. Xanadu
6.7. XtalPi
7. MARKET LANDSCAPE: HARDWARE PROVIDERS
7.1. Quantum Computing Hardware Providers: Overall Market Landscape
7.1.1. Analysis by Year of Establishment
7.1.2. Analysis by Company Size
7.1.3. Analysis by Region of Headquarters
7.1.4. Analysis by Location of Headquarters
7.1.5. Analysis by Type of Offering(s)
7.1.6. Analysis by Data Storage on Cloud
7.1.7. Analysis by Compatible Computational Approaches
7.1.8. Analysis by Type of Offering(s) and Compatible Computational Approaches
8. COMPANY PROFILES: HARDWARE PROVIDERS
8.1. Amazon Web Services
8.1.1. Company Overview
8.1.2. Financial Information
8.1.3. Service Portfolio
8.1.4. Recent Developments and Future Outlook
8.2. IBM
8.3. Microsoft
9. ACADEMIC GRANTS ANALYSIS
9.1. Analysis Methodology
9.2. Key Parameters
9.3. Analysis by Year of Grant
9.4. Analysis by Amount Awarded
9.5. Analysis by Support Period
9.6. Analysis by Study Section
9.7. Word Cloud Analysis: Emerging Focus Areas
9.8. Analysis by Administering Institute Center
9.9. Analysis by Type of Grant
9.10. Analysis by Activity Code
9.11. Analysis by Purpose of Grant
9.12. Analysis by Administering Institute Center and Support Period
9.13. Prominent Program Officers: Analysis by Number of Grants
9.14. Analysis by Location of Recipient Organizations
9.15. Analysis by Type of Organization
9.16. Popular Recipient Organizations: Analysis by Number of Grants
9.17. Popular Recipient Organizations: Analysis by Amount Awarded
10. PARTNERSHIPS AND COLLABORATIONS
10.1. Partnership Models
10.2. Quantum Computing in Drug Discovery, Drug Manufacturing and Other Services: Partnerships and Collaborations
10.3. Analysis by Year of Partnership
10.4. Analysis by Type of Partnership
10.5. Analysis by Year and Type of Partnership
10.6. Most Active Players: Analysis by Number of Partnerships
10.7. Word Cloud Analysis: Key Focus Areas
10.8. Analysis by Type of Continent
10.9. Analysis by Company Size and Type of Partnership
10.10. Local and Intercontinental Agreements
10.11. Intercontinental and Intracontinental Agreements
11. USE CASE STUDY
11.1. Overview of Quantum Computing
11.2. Applications of Quantum Computing Across Various Industries
11.3. Upcoming Trends in Quantum Computing
11.4. Future Perspectives
12. PORTER’S FIVE FORCES ANALYSIS
12.1. Methodology and Assumptions
12.2. Key Parameters
12.2.1. Threats of New Entrants
12.2.2. Bargaining Power of Buyers
12.2.3. Bargaining Power of Suppliers
12.2.4. Threats of Substitute Products
12.2.5. Rivalry among Existing Competitors
13. BLUE OCEAN STRATEGY: A STRATEGIC GUIDE FOR START-UPS TO ENTER INTO HIGHLY COMPETITIVE MARKET
13.1. Overview of Blue Ocean Strategy
13.1.1 Red Oceans
13.1.2 Blue Oceans
13.1.3 Comparison of Red Ocean Strategy and Blue Ocean Strategy
13.1.4. Quantum Computing in Drug Discovery Services Market: Blue Ocean Strategy and Shift Tools
13.1.4.1. Value Innovation
13.1.4.2. Strategy Canvas
13.1.4.3. Four Action Framework
13.1.4.4. Eliminate-Raise-Reduce-Create (ERRC) Grid
13.1.4.5. Six Path Framework
13.1.4.6. Pioneer-Migrator-Settler (PMS) Map
13.1.4.7. Three Tiers of Non-customers
13.1.4.8. Sequence of Blue Ocean Strategy
13.1.4.9. Buyer Utility Map
13.1.4.10. The Price Corridor of the Mass
13.1.4.11. Four Hurdles to Strategy Execution
13.1.4.12. Tipping Point Leadership
13.1.4.13. Fair Process
14. MARKET SIZING AND OPPORTUNITY ANALYSIS
14.1. Forecast Methodology and Key Assumptions
14.2. Quantum Computing in Drug Discovery Services Market, 2023-2035
14.2.1. Quantum Computing in Drug Discovery Services Market, 2023-2035: Analysis by Type of Drug Discovery Service Offered
14.2.1.1. Quantum Computing in Drug Discovery Services Market for Target Identification / Validation, 2023-2035
14.2.1.2. Quantum Computing in Drug Discovery Services Market for Hit Generation / Lead Identification, 2023-2035
14.2.1.3. Quantum Computing in Drug Discovery Services Market for Target Lead Optimization, 2023-2035
14.2.2. Quantum Computing in Drug Discovery Services Market, 2023-2035: Analysis by Therapeutic Area
14.2.2.1. Quantum Computing in Drug Discovery Services Market for Cardiovascular Disorders, 2023-2035
14.2.2.2. Quantum Computing in Drug Discovery Services Market for CNS Disorders, 2023-2035
14.2.2.3. Quantum Computing in Drug Discovery Services Market for Dermatological Disorders, 2023-2035
14.2.2.4. Quantum Computing in Drug Discovery Services Market for Endocrine Disorders, 2023-2035
14.2.2.5. Quantum Computing in Drug Discovery Services Market for Gastrointestinal Disorders, 2023-2035
14.2.2.6. Quantum Computing in Drug Discovery Services Market for Immunological Disorders, 2023-2035
14.2.2.7. Quantum Computing in Drug Discovery Services Market for Infectious Diseases, 2023-2035
14.2.2.8. Quantum Computing in Drug Discovery Services Market for Musculoskeletal Disorders, 2023-2035
14.2.2.9. Quantum Computing in Drug Discovery Services Market for Oncological Disorders, 2023-2035
14.2.2.10. Quantum Computing in Drug Discovery Services Market for Respiratory Disorders, 2023-2035
14.2.2.11. Quantum Computing in Drug Discovery Services Market for Others, 2023-2035
14.2.3. Quantum Computing in Drug Discovery Services Market, 2023-2035: Analysis by Key Geographical Regions
14.2.3.1. Quantum Computing in Drug Discovery Services Market in North America, 2023-2035
14.2.3.1.1. Quantum Computing in Drug Discovery Services Market in the US, 2023-2035
14.2.3.1.2. Quantum Computing in Drug Discovery Services Market in Canada, 2023-2035
14.2.3.2. Quantum Computing in Drug Discovery Services Market for Europe, 2023-2035
14.2.3.2.1. Quantum Computing in Drug Discovery Services Market in the UK, 2023-2035
14.2.3.2.2. Quantum Computing in Drug Discovery Services Market in France, 2023-2035
14.2.3.1.3. Quantum Computing in Drug Discovery Services Market in Germany, 2023-2035
14.2.3.1.4. Quantum Computing in Drug Discovery Services Market in Rest of the Europe, 2023-2035
14.2.3.3. Quantum Computing in Drug Discovery Services Market in Asia-Pacific, 2023-2035
14.2.3.3.1. Quantum Computing in Drug Discovery Services Market in China, 2023-2035
14.2.3.3.2. Quantum Computing in Drug Discovery Services Market in Japan, 2023-2035
14.2.3.3.3. Quantum Computing in Drug Discovery Services Market in Rest of Asia-Pacific, 2023-2035
14.2.3.4. Quantum Computing in Drug Discovery Services Market in Latin America, 2023-2035
14.2.3.5. Quantum Computing in Drug Discovery Services Market in Middle East and North Africa, 2023-2035
15. EXECUTIVE INSIGHTS
16. APPENDIX 1: TABULATED DATA
17. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS
To view more details on this report, click on the link
https://www.rootsanalysis.com/reports/quantum-computing-in-drug-discovery.html
You may also be interested in the following titles:
Lab Automation Market
Cannabis Testing Market
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#QuantumComputingMarket #QuantumComputingMarketSize #quantumcomputinginhealthcare #quantumcomputingindrugdiscovery #quantumcomputing
0 0 Reacties 0 Aandelen - 3D Bioprinting: Intellectual Property Landscape market 2022 – Industry Growth by 2035
The new market report titled ‘3D Bioprinting: Intellectual Property Landscape,’ published by Roots Analysis features an extensive study of some of the key historical and contemporary intellectual property (IP) documents (featuring granted patents, patent applications and other documents), describing the various types of 3D bioprinting.
The insights generated in this report have been presented across two deliverables, namely a MS Excel workbook and a MS PowerPoint deck, summarizing the ongoing trend in this domain.
To view more details on this report, click on the link:
https://www.rootsanalysis.com/reports/3d-bioprinting-intellectual-property-landscape.html
Main Chapters in the 3D Bioprinting Intellectual Property Landscape Report
Overall Intellectual Property Landscape
An analytical perspective of the various patents and affiliated IP documents that have been published related to 3D bioprinting, since 2000. An in-depth analysis of published IP documents, representing unique patent families across various global jurisdictions, featuring insightful inferences related to both historical and recent R&D trends within this domain.
Popular / Relevant Prior Art Search Expressions
An examination of IP literature, shortlisting key words and phrases used to describe 3D bioprinting. The analysis also includes details on the historical use of the aforementioned terms across different IP filings, key affiliated terms and other related trends.
Patent Valuation Analysis
A competitive benchmarking and valuation analysis of the key members of unique patent families captured in the report, taking into consideration important parameters of the patent application.
Patentability and Freedom to Operate
A systematic and Roots Proprietary approach to identify relevant areas of innovation by analyzing published IP documents, by defining the uniqueness of patented / patent pending innovations, in order to assess the scope of patentability in this domain, and pinpoint jurisdictions wherein new and / or modified claims may be filed without infringing on existing IP.
Analysis of Patent Applications and Granted 3D Bioprinting Patents
A detailed summary of the various patent applications and granted patents across different jurisdictions and their relative value in the IP ecosystem. The analysis classified the intellectual capital in terms of type of innovation and the innovation related to 3D bioprinting, thereby offering the means to identify active arenas of research and assess innovation-specific IP filing trends.
Pockets of Innovation and White Spaces
An insightful analysis of the various CPC codes used in published IP literature and their affiliated families, offering the means to identify historical and existing pockets of innovation, the analysis also features a discussion on prevalent white spaces.
Claim Analysis
One of the objectives of the report was to analyze and summarize key inferences from the independent claims mentioned in granted, active patents in the dataset. Using a systematic segregation approach, we have analyzed trends associated with the preamble, type of patent, type of claim and other key elements of a claim.
Key Companies Profiled
Hewlett-Packard (HP)
CELLINK
Organovo
Revotek
ROKIT Healthcare
T&R Biofab
Aspect Biosystems
Prellis Biologics
Advanced Solutions Life Sciences
Cyfuse
To understand the complete structure of the report, get its PDF sample copy
https://www.rootsanalysis.com/reports/3d-bioprinting-intellectual-property-landscape/request-sample.html
You may also be interested in the following titles:
Cell Therapy Manufacturing Market
Global TCR Therapy Market
You may also like to learn what our experts are sharing in Roots educational series:
Is Blue Ocean Strategy The Silver Bullet For Emerging Teleradiology Players to Achieve A Breakthrough In This Highly Competitive Market?
CAR-T Cell Therapies: Addressing Key Unmet Needs Across Various Oncological Indications
About Roots Analysis
Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.
Contact:
Ben Johnson
+1 (415) 800 3415
Ben.johnson@rootsanalysis.com
#Threedimensionalbioprinting #3dbioprintingpatents #3Dbioprinting #3Dbioprintinginvestments #3DbioprintingIPlandscape
0 0 Reacties 0 Aandelen
Meer Verhalen